Our skilled and experienced team of valuation professionals provides an in-depth and detailed financial analysis both from a buy-side and sell-side perspective, including interpreting and analyzing complex terms or securities associated with a deal.
With our expert financial analysis, we provide clients with the insight and understanding they need to strengthen their case at all stages of a business dispute or complex litigation. The situations we can help with include shareholder disputes, purchase price disputes, family disputes, joint venture disputes, pre-mature contract termination disputes, and many others.
Economic Damage Analyses
Our team examines the case closely and determines which factors should be included in the analysis. We work closely with you and help you calculate the economic damages for your clients with detailed research, documentation, and support. In addition, we also assist our clients in preparing expert opinions for litigation.
Marital Dissolutions & Business Divorces
Marital Dissolution (also known as divorce valuation) and Business Divorce refer to the process of determining the fair market value of assets and properties held by a couple during the dissolution of their marriage or holders during the dissolution of their company, respectively. We partner with you to help your clients involved in complex, high-value cases understand their current financial position and its trajectory, if appropriate, as well as to protect their financial future. We provide a reliable and supportable valuation of business interests, real estate, and other identifiable assets.
Our financial analysis services include:
- Valuing business interests and stock compensation programs
- Analyzing and calculating spending, annual cash flows, and taxable income
- Identifying and tracing marital assets
- Preparing net worth statements and financial affidavits
- Providing financial interrogatories, document tracking, and discovery requests
Why Choose Knowcraft for Valuation?
THE CLIENT AND THE ASK: A pharmaceutical company (the “Acquirer”) acquired a biotechnology company (the “Company”) in exchange for an upfront payment and certain payments contingent upon successful achievement of future regulatory and sales milestones for certain...
THE COMPANY AND THE ASK: The Company is a technology company with a business proposition to provide diagnostic services to rural India and reduce the turnaround time of getting the report from 24 hours to 1 hour. The Company was operating using multiple business...
THE COMPANY: A biotechnology company (the “Company”) engaged in the development of an Influenza vaccine as its flagship product with others in the pipeline. The lead drug was in the pre-clinical phase of development, as of the date of valuation. The Company had raised...